Live News EQUITY FLASH L impact Nov 16, 2026, 01:17 PM UTC BofA Securities Lowers Arcus Biosciences Price Target to $28 From $29 BofA Securities lowered its price target on Arcus Biosciences to $28 from $29. RCUS SquawkNews Desk